Published in Genes Dev on November 01, 1997
The interface of sigma with core RNA polymerase is extensive, conserved, and functionally specialized. Genes Dev (1999) 1.85
A human mitochondrial transcription factor is related to RNA adenine methyltransferases and binds S-adenosylmethionine. Mol Cell Biol (2002) 1.85
Structure of human mitochondrial RNA polymerase. Nature (2011) 1.82
Human mitochondrial transcription factor B1 interacts with the C-terminal activation region of h-mtTFA and stimulates transcription independently of its RNA methyltransferase activity. Mol Cell Biol (2003) 1.80
The flagellar anti-sigma factor FlgM actively dissociates Salmonella typhimurium sigma28 RNA polymerase holoenzyme. Genes Dev (1998) 1.38
Crystal structure of the transcription factor sc-mtTFB offers insights into mitochondrial transcription. Protein Sci (2001) 1.33
Functional analysis of two maize cDNAs encoding T7-like RNA polymerases. Plant Cell (1999) 1.27
Stability of the mitochondrial genome requires an amino-terminal domain of yeast mitochondrial RNA polymerase. Proc Natl Acad Sci U S A (1999) 1.24
Multiple functions of yeast mitochondrial transcription factor Mtf1p during initiation. J Biol Chem (2009) 1.06
Fluorescence mapping of the open complex of yeast mitochondrial RNA polymerase. J Biol Chem (2008) 1.01
Precise mapping and characterization of the RNA primers of DNA replication for a yeast hypersuppressive petite by in vitro capping with guanylyltransferase. Nucleic Acids Res (1998) 0.98
Identifying a core RNA polymerase surface critical for interactions with a sigma-like specificity factor. Mol Cell Biol (2000) 0.95
Transcription and RNA-processing in fission yeast mitochondria. RNA (2005) 0.95
Balance between transcription and RNA degradation is vital for Saccharomyces cerevisiae mitochondria: reduced transcription rescues the phenotype of deficient RNA degradation. Mol Biol Cell (2005) 0.95
Mechanism of transcription initiation by the yeast mitochondrial RNA polymerase. Biochim Biophys Acta (2012) 0.93
The N-terminal domain of the yeast mitochondrial RNA polymerase regulates multiple steps of transcription. J Biol Chem (2011) 0.91
Rpm2, the protein subunit of mitochondrial RNase P in Saccharomyces cerevisiae, also has a role in the translation of mitochondrially encoded subunits of cytochrome c oxidase. Genetics (2001) 0.88
Sequence and structural evolution of the KsgA/Dim1 methyltransferase family. BMC Res Notes (2008) 0.86
Rpm2p: separate domains promote tRNA and Rpm1r maturation in Saccharomyces cerevisiae mitochondria. Nucleic Acids Res (2001) 0.84
Yeast Mitochondrial Transcription Factor Mtf1 Determines the Precision of Promoter-Directed Initiation of RNA Polymerase Rpo41. PLoS One (2015) 0.79
The C-terminal region of mitochondrial single-subunit RNA polymerases contains species-specific determinants for maintenance of intact mitochondrial genomes. Mol Biol Cell (2002) 0.76
Yeast mitochondrial RNAP conformational changes are regulated by interactions with the mitochondrial transcription factor. Nucleic Acids Res (2014) 0.76
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Transformation of intact yeast cells treated with alkali cations. J Bacteriol (1983) 100.26
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
One-step gene disruption in yeast. Methods Enzymol (1983) 52.81
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene (1988) 42.65
A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics (1987) 14.69
Structure and function of bacterial sigma factors. Annu Rev Biochem (1988) 11.09
The sigma 70 family: sequence conservation and evolutionary relationships. J Bacteriol (1992) 9.07
In vitro mutagenesis and plasmid shuffling: from cloned gene to mutant yeast. Methods Enzymol (1991) 8.90
RNA from the yeast transposable element Ty1 has both ends in the direct repeats, a structure similar to retrovirus RNA. Proc Natl Acad Sci U S A (1983) 8.61
An attempt to unify the structure of polymerases. Protein Eng (1990) 7.93
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins. Nucleic Acids Res (1986) 7.28
Regulation of the yeast HO gene. Cold Spring Harb Symp Quant Biol (1985) 6.27
Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol Cell Biol (1995) 5.71
Protein-protein interactions: methods for detection and analysis. Microbiol Rev (1995) 5.08
Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev (1995) 3.88
Yeast mitochondrial RNA polymerase is homologous to those encoded by bacteriophages T3 and T7. Cell (1987) 3.83
Crystal structure of bacteriophage T7 RNA polymerase at 3.3 A resolution. Nature (1993) 3.69
General initiation factors for RNA polymerase II. Annu Rev Biochem (1993) 3.69
Guide to yeast genetics and molecular biology. Methods Enzymol (1991) 3.61
Crystal structure of a sigma 70 subunit fragment from E. coli RNA polymerase. Cell (1996) 2.90
Characterization of the Escherichia coli transcription factor sigma 70: localization of a region involved in the interaction with core RNA polymerase. Biochemistry (1989) 2.40
Amino-terminal amino acids modulate sigma-factor DNA-binding activity. Genes Dev (1993) 2.30
Identification of the gene encoding the human mitochondrial RNA polymerase (h-mtRPOL) by cyberscreening of the Expressed Sequence Tags database. Hum Mol Genet (1997) 2.15
The yeast mitochondrial RNA polymerase specificity factor, MTF1, is similar to bacterial sigma factors. J Biol Chem (1991) 1.88
Related RNA polymerase-binding regions in human RAP30/74 and Escherichia coli sigma 70. Science (1991) 1.76
Domain organization of the Escherichia coli RNA polymerase sigma 70 subunit. J Mol Biol (1996) 1.73
A nonanucleotide sequence involved in promotion of ribosomal RNA synthesis and RNA priming of DNA replication in yeast mitochondria. Nucleic Acids Res (1982) 1.72
Three-dimensional structure of E. coli core RNA polymerase: promoter binding and elongation conformations of the enzyme. Cell (1995) 1.71
Nuclear gadgets in mitochondrial DNA replication and transcription. Trends Biochem Sci (1991) 1.64
Glucose repression of yeast mitochondrial transcription: kinetics of derepression and role of nuclear genes. Mol Cell Biol (1994) 1.62
Release of the yeast mitochondrial RNA polymerase specificity factor from transcription complexes. J Biol Chem (1994) 1.53
Regulation of mitochondrial gene expression in Saccharomyces cerevisiae. Int Rev Cytol (1994) 1.49
A nuclear gene essential for mitochondrial replication suppresses a defect of mitochondrial transcription in Saccharomyces cerevisiae. Mol Gen Genet (1988) 1.43
A mutant sigma 32 with a small deletion in conserved region 3 of sigma has reduced affinity for core RNA polymerase. J Bacteriol (1992) 1.42
Sequences homologous to yeast mitochondrial and bacteriophage T3 and T7 RNA polymerases are widespread throughout the eukaryotic lineage. Nucleic Acids Res (1996) 1.36
RPO41-independent maintenance of [rho-] mitochondrial DNA in Saccharomyces cerevisiae. Mol Cell Biol (1990) 1.35
A Saccharomyces cerevisiae mitochondrial transcription factor, sc-mtTFB, shares features with sigma factors but is functionally distinct. Mol Cell Biol (1995) 1.27
Functional domains of human RAP74 including a masked polymerase binding domain. J Biol Chem (1995) 1.26
A study of the quaternary structure of Escherichia coli RNA polymerase using bis(imido esters). Biochemistry (1977) 1.25
A sigma32 mutant with a single amino acid change in the highly conserved region 2.2 exhibits reduced core RNA polymerase affinity. Proc Natl Acad Sci U S A (1997) 1.23
PCR mutagenesis identifies a polymerase-binding sequence of sigma 54 that includes a sigma 70 homology region. J Bacteriol (1995) 1.19
Mitochondrial transcription: is a pattern emerging? Mol Microbiol (1993) 1.08
A single amino acid substitution in sigma E affects its ability to bind core RNA polymerase. J Bacteriol (1995) 1.04
Binding of the sigma 70 protein to the core subunits of Escherichia coli RNA polymerase, studied by iron-EDTA protein footprinting. Proc Natl Acad Sci U S A (1996) 1.03
Cloning and characterization of the Neurospora crassa cyt-5 gene. A nuclear-coded mitochondrial RNA polymerase with a polyglutamine repeat. J Biol Chem (1996) 0.86
The yeast proteome database (YPD) and Caenorhabditis elegans proteome database (WormPD): comprehensive resources for the organization and comparison of model organism protein information. Nucleic Acids Res (2000) 17.68
The Yeast Proteome Database (YPD): a model for the organization and presentation of genome-wide functional data. Nucleic Acids Res (1999) 7.59
Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". Genome Res (2001) 5.10
Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol (2000) 4.31
Isolation and partial characterization of the multiple forms of deoxyribonucleic acid-dependent ribonucleic acid polymerase in the mouse myeloma, MOPC 315. J Biol Chem (1974) 3.84
A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling. Mol Cell Biol (1999) 2.80
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55
Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme. Mol Cell Biol (1997) 2.37
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes (1999) 2.21
Paf1p, an RNA polymerase II-associated factor in Saccharomyces cerevisiae, may have both positive and negative roles in transcription. Mol Cell Biol (1996) 2.19
Factors affecting insertion time and patient discomfort during colonoscopy. Gastrointest Endosc (2000) 2.13
Transcriptional activation in an improved whole-cell extract from Saccharomyces cerevisiae. Mol Cell Biol (1991) 1.88
The yeast mitochondrial RNA polymerase specificity factor, MTF1, is similar to bacterial sigma factors. J Biol Chem (1991) 1.88
Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc Natl Acad Sci U S A (1997) 1.83
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006. Clin Pharmacol Ther (2007) 1.70
Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle regulation, protein synthesis, and lipid and nucleic acid metabolism. Mol Genet Genomics (2002) 1.67
A multicomponent mitochondrial RNA polymerase from Saccharomyces cerevisiae. J Biol Chem (1985) 1.67
Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology (2000) 1.65
Glucose repression of yeast mitochondrial transcription: kinetics of derepression and role of nuclear genes. Mol Cell Biol (1994) 1.62
A transcription map of a yeast centromere plasmid: unexpected transcripts and altered gene expression. Nucleic Acids Res (1985) 1.62
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.60
In vitro transcriptional activation by a metabolic intermediate: activation by Leu3 depends on alpha-isopropylmalate. Science (1992) 1.57
Where has the tumor gone? The characteristics of cases of negative pathologic diagnosis after endoscopic mucosal resection. Endoscopy (2009) 1.55
Release of the yeast mitochondrial RNA polymerase specificity factor from transcription complexes. J Biol Chem (1994) 1.53
A novel collection of accessory factors associated with yeast RNA polymerase II. Protein Expr Purif (1996) 1.49
Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res (1999) 1.47
[Increased expression of hypoxia-inducible factor-1α and connective tissue growth factor accompanied by fibrosis in the rat testis of varicocele]. Actas Urol Esp (2012) 1.44
Combination therapy of testosterone enanthate and tadalafil on PDE5 inhibitor non-reponders with severe and intermediate testosterone deficiency. Int J Impot Res (2012) 1.42
DNA-dependent RNA polymerase levels during the response of human peripheral lymphocytes to phytohemagglutinin. Cell (1975) 1.39
Endoscopic band ligation of active cardiac variceal bleeding. Endoscopy (2006) 1.38
Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc Natl Acad Sci U S A (1992) 1.36
High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis (1995) 1.34
Determinants of paclitaxel penetration and accumulation in human solid tumor. J Pharmacol Exp Ther (1999) 1.32
A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators. Nucleic Acids Res (1997) 1.31
Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res (2001) 1.31
A case of spontaneous pneumomediastinum and pneumopericardium in a young adult. Korean J Intern Med (2001) 1.30
Purification and characterization of the yeast transcriptional activator GAL4. J Biol Chem (1990) 1.29
Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol (2001) 1.27
Accurate initiation by RNA polymerase II in a whole cell extract from Saccharomyces cerevisiae. J Biol Chem (1990) 1.26
Frequency of cytochrome P450 2C9 mutant alleles in a Korean population. Br J Clin Pharmacol (2001) 1.26
Transcription of specific adenovirus genes in isolated nuclei by exogenous RNA polymerases. J Biol Chem (1977) 1.26
Altered promoter selection by a novel form of Bacillus subtilis RNA polymerase. Proc Natl Acad Sci U S A (1979) 1.24
Determinants of drug delivery and transport to solid tumors. J Control Release (2001) 1.24
Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children. Pediatr Infect Dis J (1995) 1.22
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol (1999) 1.22
Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol (2000) 1.21
Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology (2000) 1.21
A transcriptionally active form of GAL4 is phosphorylated and associated with GAL80. Mol Cell Biol (1992) 1.21
Viral RNA synthesis and levels of DNA-dependent RNA polymerases during replication of adenovirus 2. J Virol (1975) 1.18
mRNA transcription in nuclei isolated from Saccharomyces cerevisiae. Mol Cell Biol (1986) 1.18
Computational model of intracellular pharmacokinetics of paclitaxel. J Pharmacol Exp Ther (2000) 1.16
Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Cancer Res (1998) 1.15
Intussusception after gastric surgery. Endoscopy (2005) 1.15
Transcriptional corepression in vitro: a Mot1p-associated form of TATA-binding protein is required for repression by Leu3p. Mol Cell Biol (1996) 1.14
BRAF mutations in non-Hodgkin's lymphoma. Br J Cancer (2003) 1.13
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine (1995) 1.12
Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res (1999) 1.12
Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst (2001) 1.09
Construction of a BAC library of Korean ginseng and initial analysis of BAC-end sequences. Mol Genet Genomics (2004) 1.08
Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract (2001) 1.08
Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med (2001) 1.08
Purification, properties, and subunit structure of deoxyribonucleic acid-dependent ribonucleic acid polymerase III from uninfected and adenovirus 2-infected KB cells. J Biol Chem (1977) 1.08
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol (2007) 1.07
Use of yeast nuclear DNA sequences to define the mitochondrial RNA polymerase promoter in vitro. Mol Cell Biol (1989) 1.07
Expression of the Saccharomyces cerevisiae GAL7 gene on autonomous plasmids. Mol Cell Biol (1984) 1.06
The EGD1 product, a yeast homolog of human BTF3, may be involved in GAL4 DNA binding. Mol Cell Biol (1992) 1.04
Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus. Diabet Med (2006) 1.04
VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.03
Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int (2007) 1.03
Anatomic location and somatotopic arrangement of the corticospinal tract at the cerebral peduncle in the human brain. AJNR Am J Neuroradiol (2011) 1.03
Longitudinal fMRI study for locomotor recovery in patients with stroke. Neurology (2006) 1.02
Diagnosis and control measures of the 2010 outbreak of foot-and-mouth disease A type in the Republic of Korea. Transbound Emerg Dis (2012) 1.02
Association between birth weight and insulin sensitivity in healthy young men in Korea: role of visceral adiposity. Diabetes Res Clin Pract (2000) 1.01
Quantitative binding site model generation: compass applied to multiple chemotypes targeting the 5-HT1A receptor. J Med Chem (1995) 1.01
Two forms of RPO41-dependent RNA polymerase. Regulation of the RNA polymerase by glucose repression may control yeast mitochondrial gene expression. J Biol Chem (1988) 1.01
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene (2001) 1.01
Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation. Br J Pharmacol (2012) 1.01
Cytoplasmic accumulation of a normally mitochondrial malonyl-CoA decarboxylase by the use of an alternate transcription start site. Arch Biochem Biophys (1992) 1.00
Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol (1996) 1.00
Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas. APMIS (2000) 1.00
Controlled cellular orientation on PLGA microfibers with defined diameters. Biomed Microdevices (2009) 0.99
Rupture of pectoralis major muscle. A case report and review of literature. J Bone Joint Surg Am (1970) 0.99
cDNA sequence analysis confirms that the etiologic agent of callitrichid hepatitis is lymphocytic choriomeningitis virus. J Virol (1995) 0.99
Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma. Am J Pathol (1999) 0.98
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19. Clin Pharmacol Ther (2001) 0.98
Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo. Gene Ther (2004) 0.98
Control measures implemented during the 2002 foot-and-mouth disease outbreak in the Republic of Korea. Vet Rec (2004) 0.98
Transcription of multiple copies of the yeast GAL7 gene is limited by specific factors in addition to GAL4. Mol Gen Genet (1987) 0.97
Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. Bioorg Med Chem (2001) 0.97
Differentiation of Salmonella enterica serotype gallinarum biotype pullorum from biotype gallinarum by analysis of phase 1 flagellin C gene (fliC). J Microbiol Methods (2000) 0.97
Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol (2001) 0.96
Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators. Genes Brain Behav (2009) 0.96
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. Diabetes Obes Metab (2010) 0.95
Gal4 protein binding is required but not sufficient for derepression and induction of GAL2 expression. J Biol Chem (1993) 0.95
Identifying a core RNA polymerase surface critical for interactions with a sigma-like specificity factor. Mol Cell Biol (2000) 0.95
Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients. Clin Exp Dermatol (2005) 0.95